References
Ashokkumar B,
Mohammed ZM,
Vaziri ND and
Said HM
(2007)
Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells.
American Journal of Clinical Nutrition
86(1):
159–166.
Bailey LB and
Berry RJ
(2005)
Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage.
American Journal of Clinical Nutrition
81(5):
1213S–1217S.
Bailey RL,
Mills JL,
Yetley EA et al.
(2010)
Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged ≥60 y in the United States.
American Journal of Clinical Nutrition
92(2):
383–389.
Bailey SW and
Ayling JE
(2009)
The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake.
Proceedings of the National Academy of Sciences of the USA
106(36):
15424–15429.
Berry RJ,
Li Z,
Erickson JD et al.
(1999)
Prevention of neural‐tube defects with folic acid in China.
New England Journal of Medicine
341(20):
1485–1490.
Blom HJ,
Shaw GM,
den Heijer M and
Finnell RH
(2006)
Neural tube defects and folate: case far from closed.
Nature Reviews Neuroscience
7(9):
724–731.
Botto LD,
Olney RS and
Erickson JD
(2004)
Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
American Journal of Medical Genetics Part C: Seminars in Medical Genetics
125C(1):
12–21.
Campbell NC
(1996)
How safe are folic acid supplements?
Archives of Internal Medicine
156(15):
1638–1644.
Carmel R
(2005)
Folic acid.
In: Shils ME,
Shike M,
Ross AC,
Caballero B and
Cousins RJ (eds)
In: Modern Nutrition in Health and Disease,
pp. 470–481.
Baltimore, MD: Lippincott Williams & Wilkins.
Centers for Disease Control and Prevention (CDC)
(2010)
CDC grand rounds: additional opportunities to prevent neural tube defects with folic acid fortification.
Morbidity and Mortality Weekly Report
59(31):
980–984.
Clarke R,
Halsey J,
Bennett D and
Lewington S
(2011)
Homocysteine and vascular disease: review of published results of the homocysteine‐lowering trials.
Journal of Inherited Metabolic Disease
34(1):
83–91.
Clarke R,
Halsey J,
Lewington S et al.
(2010)
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause‐specific mortality: meta‐analysis of 8 randomized trials involving 37 485 individuals.
Archives of Internal Medicine
170(18):
1622–1631.
Colapinto CK,
O'Connor DL and
Tremblay MS
(2011)
Folate status of the population in the Canadian Health Measures Survey.
Canadian Medical Association Journal
183(2):
E100–E106.
Cole BF,
Baron JA,
Sandler RS et al.
(2007)
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
JAMA
297(21):
2351–2359.
Cooney CA,
Dave AA and
Wolff GL
(2002)
Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring.
Journal of Nutrition
132(8):
2393S–2400S.
Czeizel AE and
Dudás I
(1992)
Prevention of the first occurrence of neural‐tube defects by periconceptional vitamin supplementation.
New England Journal of Medicine
327(26):
1832–1835.
De Wals P,
Tairou F,
Van Allen MI et al.
(2007)
Reduction in neural‐tube defects after folic acid fortification in Canada.
New England Journal of Medicine
357(2):
135–142.
Devlin AM,
Ling E,
Peerson JM et al.
(2000)
Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia.
Human Molecular Genetics
9(19):
2837–2844.
Douaud G,
Refsum H,
de Jager CA et al.
(2013)
Preventing Alzheimer's disease‐related gray matter atrophy by B‐vitamin treatment.
Proceedings of the National Academy of Sciences of the USA
110(23):
9523–9528.
Ebbing M,
Bønaa K,
Nygård O et al.
(2009)
Cancer incidence and mortality after treatment with folic acid and vitamin B12.
JAMA
302(19):
2119–2126.
Figueiredo JC,
Grau MV,
Haile RW et al.
(2009)
Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Journal of the National Cancer Institute
101(6):
432–435.
Figueiredo JC,
Mott LA,
Giovannucci E et al.
(2011)
Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.
International Journal of Cancer
129(1):
192–203.
Gibson TM,
Weinstein SJ,
Pfeiffer RM et al.
(2011)
Pre‐ and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States.
American Journal of Clinical Nutrition
94(4):
1053–1062.
Halsted CH,
Villanueva JA,
Devlin AM and
Chandler CJ
(2002)
Metabolic interactions of alcohol and folate.
Journal of Nutrition
132(8):
2367S–2372S.
Hirsch S,
Sanchez H,
Albala C et al.
(2009)
Colon cancer in Chile before and after the start of the flour fortification program with folic acid.
European Journal of Gastroenterology & Hepatology
21(4)
:436–439.
Homocysteine Studies Collaboration
(2002)
Homocysteine and risk of ischemic heart disease and stroke: a meta‐analysis.
JAMA
288(16):
2015–2022.
Institute of Medicine (IOM)
(1998)
Folate.
In: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline, pp.196–305.
Washington, DC: National Academy Press.
Kalmbach RD,
Choumenkovitch SF,
Troen AM et al.
(2008)
Circulating folic acid in plasma: relation to folic acid fortification.
American Journal of Clinical Nutrition
88(3):
763–768.
Kim YI
(2007)
Folate and colorectal cancer: an evidence‐based critical review.
Molecular Nutrition & Food Research
51(3):
267–292.
Kim YI
(2009)
Role of the MTHFR polymorphisms in cancer risk modification and treatment.
Future Oncology
5(4):
523–542.
Ly A,
Hoyt L,
Crowell J and
Kim YI
(2012)
Folate and DNA methylation.
Antioxidants & Redox Signaling
17(2):
302–326.
Mason JB,
Dickstein A,
Jacques PF et al.
(2007)
A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis.
Cancer Epidemiology Biomarkers & Prevention
16(7):
1325–1329.
Morris MS,
Jacques PF,
Rosenberg IH and
Selhub J
(2007)
Folate and vitamin B‐12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification.
American Journal of Clinical Nutrition
85(1):
193–200.
MRC Vitamin Study Research Group
(1991)
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
Lancet
338(8760):
131–137.
Pfeiffer CM,
Caudill SP,
Gunter EW,
Osterloh J and
Sampson EJ
(2005)
Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000.
American Journal of Clinical Nutrition
82(2):
442–450.
Pfeiffer CM,
Hughes JP,
Lacher DA et al.
(2012)
Estimation of trends in serum and RBC folate in the U.S. population from pre‐ to postfortification using assay‐adjusted data from the NHANES 1988–2010.
Journal of Nutrition
142(5):
886–893.
Qi YP,
Do AN,
Hamner HC,
Pfeiffer CM and
Berry RJ
(2014)
The prevalence of low serum vitamin B‐12 status in the absence of anemia or macrocytosis did not increase among older U.S. adults after mandatory folic acid fortification.
Journal of Nutrition
144(2):
170–176.
Radimer K,
Bindewald B,
Hughes J et al.
(2004)
Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000.
American Journal of Epidemiology
160(4):
339–349.
Reynolds E
(2006)
Vitamin B12, folic acid, and the nervous system.
Lancet Neurology
5(11):
949–960.
Shane B
(2010)
Folate chemistry and metabolism.
In: Bailey LB (ed.)
Folate in Health and Disease,
pp. 1–24.
Boca Raton, FL: CRC Press.
Smith AD,
Kim YI and
Refsum H
(2008)
Is folic acid good for everyone?
American Journal of Clinical Nutrition
87(3):
517–533.
Smithells RW,
Sheppard S and
Schorah CJ
(1976)
Vitamin dificiencies and neural tube defects.
Archives of Disease in Childhood
51(12):
944–950.
Stevens VL,
McCullough ML,
Sun J et al.
(2011)
High levels of folate from supplements and fortification are not associated with increased risk of colorectal cancer.
Gastroenterology
141(1):
98–105.
Sweeney M,
Staines A,
Daly L et al.
(2009)
Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification?
BMC Public Health
9(1):
295–301.
Tamura T and
Picciano MF
(2006)
Folate and human reproduction.
American Journal of Clinical Nutrition
83(5):
993–1016.
Troen AM,
Mitchell B,
Sorensen B et al.
(2006)
Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women.
Journal of Nutrition
136(1):
189–194.
Vargas‐Martinez C,
Ordovas JM,
Wilson PW and
Selhub J
(2002)
The glutamate carboxypeptidase gene II (C>T) polymorphism does not affect folate status in the Framingham Offspring cohort.
Journal of Nutrition
132(6):
1176–1179.
Visentin M,
Diop‐Bove N,
Zhao R and
Goldman ID
(2014)
The intestinal absorption of folates.
Annual Review of Physiology
76(1):
251–274.
Vollset SE,
Clarke R,
Lewington S et al.
(2013)
Effects of folic acid supplementation on overall and site‐specific cancer incidence during the randomised trials: meta‐analyses of data on 50 000 individuals.
Lancet
381(9871)
:1029–1036.
Wang X,
Qin X,
Demirtas H et al.
(2007)
Efficacy of folic acid supplementation in stroke prevention: a meta‐analysis.
Lancet
369(9576)
:1876–1882.
Waterland RA,
Dolinoy DC,
Lin JR et al.
(2006)
Maternal methyl supplements increase offspring DNA methylation at axin fused.
Genesis
44(9):
401–406.
World Health Organization (WHO)
(2012)
Serum and red blood cell folate concentrations for assessing folate status in populations.
Vitamin and Mineral Nutrition Information System.
Geneva: World Health Organization.
http://apps.who.int/iris/bitstream/10665/75584/1/WHO_NMH_NHD_EPG_12.1_eng.pdf
Wien TN,
Pike E,
Wisløff T et al.
(2012)
Cancer risk with folic acid supplements: a systematic review and meta‐analysis.
BMJ Open
2(1):
e000653.
Yang Q,
Botto LD,
Erickson JD et al.
(2006)
Improvement in stroke mortality in Canada and the United States, 1990 to 2002.
Circulation
113(10):
1335–1343.
Further Reading
Ciappio ED,
Mason JB and
Crott JW
(2011)
Maternal one‐carbon nutrient intake and cancer risk in offspring.
Nutrition Reviews
69(10):
561–571.
Hoffbrand AV and
Weir DG
(2001)
The history of folic acid.
British Journal of Haematology
113(3):
579–589.
Kim D,
Smith‐Warner S,
Spiegelman D et al.
(2010)
Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer.
Cancer Causes & Control
21(11):
1919–1930.
Lucock M and
Yates Z
(2005)
Folic acid – vitamin and panacea or genetic time bomb?
Nature Reviews Genetics
6(3):
235–240.
Scientific Advisory Committee on Nutrition Agency
(2006)
Folate and Disease Prevention.
Norwich: The Stationary Office.
http://www.sacn.gov.uk/pdfs/folate_and_disease_prevention_report.pdf